ストックスクリーナーアプリを入手
67.81
1.15%
0.77
プレマーケット:
67.61
-0.20
-0.29%
前日終値:
$67.04
開ける：
$66.98
24時間の取引高:
942.29K
Relative Volume:
1.18
時価総額：
$3.08B
収益：
$1.32B
当期純損益:
$175.44M
株価収益率:
18.63
EPS:
3.6395
ネットキャッシュフロー:
$308.08M
1週間 パフォーマンス:
+3.54%
1か月 パフォーマンス:
+14.91%
6か月 パフォーマンス:
-16.64%
1年 パフォーマンス:
-0.04%
1日の値動き範囲:
$66.19
$68.33
1週間の範囲:
$64.50
$68.33
52週間の値動き範囲:
$47.31
$87.32
Haemonetics Corp Stock (HAE) Company Profile
Compare HAE vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
HAE
Haemonetics Corp
|
67.81 | 3.05B | 1.32B | 175.44M | 308.08M | 3.6395 |
ABT
Abbott Laboratories
|
85.60 | 150.32B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
305.09 | 117.93B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
73.81 | 97.02B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
48.31 | 72.99B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.47 | 49.50B | 6.30B | 1.07B | 1.09B | 1.8406 |
Haemonetics Corp Stock (HAE) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-15 | ダウングレード | Needham | Buy → Hold |
| 2025-12-11 | ダウングレード | Citigroup | Buy → Neutral |
| 2025-08-11 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2025-08-08 | 繰り返されました | Barrington Research | Outperform |
| 2025-08-08 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2025-07-09 | アップグレード | Citigroup | Neutral → Buy |
| 2025-06-26 | 開始されました | Robert W. Baird | Outperform |
| 2025-02-07 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2024-12-06 | 開始されました | JP Morgan | Overweight |
| 2024-11-08 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2024-09-13 | 開始されました | CL King | Buy |
| 2024-09-11 | 開始されました | BofA Securities | Neutral |
| 2024-09-10 | 開始されました | BTIG Research | Buy |
| 2024-06-12 | アップグレード | Needham | Hold → Buy |
| 2022-10-13 | 開始されました | Mizuho | Buy |
| 2022-01-27 | ダウングレード | Needham | Buy → Hold |
| 2021-12-15 | ダウングレード | Citigroup | Buy → Neutral |
| 2021-08-17 | 再開されました | Raymond James | Outperform |
| 2021-06-17 | 開始されました | Citigroup | Buy |
| 2021-05-14 | アップグレード | CJS Securities | Market Perform → Market Outperform |
| 2021-04-20 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2021-04-19 | ダウングレード | CJS Securities | Market Outperform → Market Perform |
| 2021-02-03 | アップグレード | Barrington Research | Mkt Perform → Outperform |
| 2021-01-21 | ダウングレード | Barrington Research | Outperform → Mkt Perform |
| 2020-11-05 | アップグレード | Barrington Research | Mkt Perform → Outperform |
| 2020-05-06 | ダウングレード | Barrington Research | Outperform → Mkt Perform |
| 2020-03-31 | アップグレード | CJS Securities | Market Perform → Market Outperform |
| 2020-01-10 | 開始されました | Needham | Buy |
| 2019-08-07 | 繰り返されました | Barrington Research | Outperform |
| 2019-05-14 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2019-05-08 | 繰り返されました | Barrington Research | Outperform |
| 2018-08-09 | 繰り返されました | Barrington Research | Outperform |
| 2018-02-07 | 繰り返されました | Barrington Research | Outperform |
| 2018-01-02 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2017-11-08 | 繰り返されました | Barrington Research | Outperform |
| 2017-08-08 | アップグレード | Barrington Research | Mkt Perform → Outperform |
| 2017-07-13 | アップグレード | JMP Securities | Mkt Perform → Mkt Outperform |
| 2017-02-07 | ダウングレード | Barrington Research | Outperform → Mkt Perform |
| 2016-11-08 | アップグレード | Barrington Research | Mkt Perform → Outperform |
| 2016-11-07 | 繰り返されました | The Benchmark Company | Hold |
| 2016-09-20 | ダウングレード | CJS Securities | Market Outperform → Market Perform |
| 2016-08-15 | ダウングレード | Sidoti | Buy → Neutral |
| 2016-08-02 | 繰り返されました | Jefferies | Buy |
| 2016-08-02 | 繰り返されました | The Benchmark Company | Hold |
すべてを表示
Haemonetics Corp (HAE) 最新ニュース
HAE Maintained by Citigroup -- Price Target Raised to $70 - GuruFocus
Citi Maintains Haemonetics(HAE.US) With Hold Rating, Raises Target Price to $70 - 富途牛牛
Why Haemonetics NYSE Composite Earnings Sparked Attention? - Kalkine Media
Haemonetics' (NYSE:HAE) Conservative Accounting Might Explain Soft Earnings - simplywall.st
HAE News | HAEMONETICS CORP/MASS (NYSE:HAE) - ChartMill
Why Haemonetics (HAE) Is Up 14.3% After Earnings Beat And BofA Upgrade And What's Next - Yahoo Finance
Is It Time To Reassess Haemonetics (HAE) After The Recent Share Price Jump - simplywall.st
Haemonetics (HAE) Stock Is Up, What You Need To Know - Yahoo Finance
Medical Devices & SuppliesSpecialty Stocks Q1 Highlights: Haemonetics (NYSE:HAE) - Yahoo Finance
Haemonetics (HAE) Upgraded to Buy by Bank of America, Target Pri - GuruFocus
HAE Upgraded by B of A Securities -- Price Target Raised to $80 - GuruFocus
Haemonetics (HAE) Upgraded to Buy by Bank of America, Shares Cli - GuruFocus
Investing in Haemonetics (HAE)? Don't Miss Assessing Its International Revenue Trends - Yahoo! Finance Canada
This Texas Instruments Analyst Turns Bullish; Here Are Top 4 Upgrades For Friday - Benzinga
BofA upgrades Haemonetics stock rating on conservative guidance - Investing.com
BofA upgrades Haemonetics stock rating on conservative guidance By Investing.com - Investing.com Canada
Is It Too Late to Buy Haemonetics Corp (HAE) After 4.0% Rally? G - GuruFocus
Does Haemonetics (HAE) Have Enduring Growth Potential? - Insider Monkey
Q3 2026 Haemonetics Corp Earnings Call Transcript - GuruFocus
Haemonetics Corp 2026 Annual Report: Business Overview, Market Segments, Products, and Competitive Landscape - Minichart
Haemonetics (NYSE: HAE) outlines segment shifts, major customers and risks - Stock Titan
Haemonetics (HAE) EVP and General Counsel receives 28,424 RSUs, 2,913 shares withheld for taxes - Stock Titan
[Form 4] HAEMONETICS CORP Insider Trading Activity - Stock Titan
Haemonetics (NYSE: HAE) CFO granted 29,312 RSUs with tax withholding - Stock Titan
Haemonetics (NYSE: HAE) VP granted 2,220 RSUs, 197 shares withheld for tax - Stock Titan
Haemonetics (HAE) EVP Roy Galvin granted RSUs as 879 shares withheld for taxes - Stock Titan
Haemonetics (HAE) SVP granted RSUs while shares withheld to cover taxes - Stock Titan
Haemonetics (HAE) CEO receives 78,344 RSUs and has shares withheld for taxes - Stock Titan
Does Haemonetics' (HAE) Buyback-Funded Loss Quarter Hint at Shifting Earnings Quality Priorities? - simplywall.st
Haemonetics (HAE) Valuation Check As Earnings Pressure And Options Volatility Raise Questions - simplywall.st
HAE Stock Price, Quote & Chart | HAEMONETICS CORP/MASS (NYSE:HAE) - ChartMill
Haemonetics (HAE) Q4 2026 Earnings Transcript - AOL.com
Haemonetics Sees FY27 Revenue, Adjusted EPS Up 4%-7% >HAE - Moomoo
Haemonetics Corp (HAE) Shares Surge 5.5% -- What GF Score of 74 Tells Investors - GuruFocus
North Peak group files 13G/A, Haemonetics (NYSE: HAE) shows ≤5% ownership - Stock Titan
Is the Options Market Predicting a Spike in Haemonetics Stock? - Yahoo Finance
HAE Maintained by Barrington Research -- Price Target Lowered to $89 - GuruFocus
Haemonetics Corp at Bank of America Global Healthcare Conference Transcript - GuruFocus
Barrington Maintains Haemonetics(HAE.US) With Buy Rating, Cuts Target Price to $89 - 富途牛牛
A Look At Haemonetics (HAE) Valuation After Recent Share Price Weakness - Yahoo Finance
TradingKey - TradingKey
Why Haemonetics Stock Is Dropping So Sharply - TipRanks
Why Haemonetics (HAE) Is Down 9.5% After Mixed FY26 Results And FY27 Outlook Reset - simplywall.st
Haemonetics Q4 Earnings Call Highlights - sharewise.com
Haemonetics Corporation (NYSE:HAE) Q4 2026 Earnings Call Transcript - Insider Monkey
A Look At Haemonetics (HAE) Valuation After Q4 Loss And Sector-Wide Medical Device Sell Off - simplywall.st
Haemonetics Earnings Call Highlights Growth Amid Headwinds - TipRanks
HAE Maintained by JP Morgan -- Price Target Lowered to $62.00 - GuruFocus
J.P. Morgan Maintains Haemonetics(HAE.US) With Hold Rating, Maintains Target Price $62 - 富途牛牛
Baird Maintains Haemonetics(HAE.US) With Buy Rating, Cuts Target Price to $67 - 富途牛牛
Haemonetics Corp (HAE) 財務データ
収益
当期純利益
現金流量
EPS
0.59%
1.94%
大文字化:
|
ボリューム (24 時間):